Page last updated: 2024-08-25

rosiglitazone and Carcinoma, Papillary, Follicular

rosiglitazone has been researched along with Carcinoma, Papillary, Follicular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honsawek, S; Keelawat, S; Ruangvejvorachai, P; Tepmongkol, S	1

Trials

1 trial(s) available for rosiglitazone and Carcinoma, Papillary, Follicular

Article	Year
Rosiglitazone effect on radioiodine uptake in thyroid carcinoma patients with high thyroglobulin but negative total body scan: a correlation with the expression of peroxisome proliferator-activated receptor-gamma. Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Dose-Response Relationship, Drug; Female; Humans; Iodine; Iodine Radioisotopes; Male; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging	2008

Article

Year

Rosiglitazone effect on radioiodine uptake in thyroid carcinoma patients with high thyroglobulin but negative total body scan: a correlation with the expression of peroxisome proliferator-activated receptor-gamma.

Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Dose-Response Relationship, Drug; Female; Humans; Iodine; Iodine Radioisotopes; Male; Middle Aged; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging

2008